AGADA Biosciences Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 20


  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 4

AGADA Biosciences General Information


Developer of orphan drug development platform designed for neuromuscular disorders. The company's service includes centralized preclinical drug efficacy testing and phenotyping services for neuromuscular disorders, with specific expertise in murine models of Duchenne muscular dystrophy, enabling companies to provide normative values and benchmarking in multiple murine models of neuromuscular disease.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Corporate Office
  • MP-1115 1498 Lower Water Street
  • Suite 411
  • Halifax, Nova Scotia B3J 3R5
  • Canada
+1 (902) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AGADA Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 01-Dec-2022 000.00 Completed Generating Revenue
4. Grant 08-Jul-2019 00000 000.00 Completed Generating Revenue
3. Accelerator/Incubator 01-Jan-2016 000.00 Completed Generating Revenue
2. Accelerator/Incubator 21-Oct-2014 $23.4K $23.4K Completed Startup
1. Accelerator/Incubator Completed Startup
To view AGADA Biosciences’s complete valuation and funding history, request access »

AGADA Biosciences Executive Team (3)

Name Title Board Seat Contact Info
Eric Hoffman Ph.D Co-Founder, Chief Executive Officer, Vice President & Board Member
Amanda Mullen Chief Operating Officer & Chairperson
Kanneboyina Nagaraju Ph.D Co-Founder, President & Board Member
To view AGADA Biosciences’s complete executive team members history, request access »

AGADA Biosciences Board Members (2)

Name Representing Role Since
Amanda Mullen AGADA Biosciences Chief Operating Officer & Chairperson 000 0000
Kanneboyina Nagaraju Ph.D Self Co-Founder, President & Board Member 000 0000
To view AGADA Biosciences’s complete board members history, request access »

AGADA Biosciences Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

AGADA Biosciences Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Invest Nova Scotia Venture Capital Minority 000 0000 000000 0
Duchenne UK Corporation 000 0000 000000 0
Life Sciences Nova Scotia Accelerator/Incubator 000 0000 000000 0
Global Business Accelerator Accelerator/Incubator 000 0000 000000 0
To view AGADA Biosciences’s complete investors history, request access »

AGADA Biosciences FAQs

  • When was AGADA Biosciences founded?

    AGADA Biosciences was founded in 2013.

  • Who is the founder of AGADA Biosciences?

    Eric Hoffman Ph.D and Kanneboyina Nagaraju Ph.D are the founders of AGADA Biosciences.

  • Who is the CEO of AGADA Biosciences?

    Eric Hoffman Ph.D is the CEO of AGADA Biosciences.

  • Where is AGADA Biosciences headquartered?

    AGADA Biosciences is headquartered in Halifax, Canada.

  • What is the size of AGADA Biosciences?

    AGADA Biosciences has 20 total employees.

  • What industry is AGADA Biosciences in?

    AGADA Biosciences’s primary industry is Drug Discovery.

  • Is AGADA Biosciences a private or public company?

    AGADA Biosciences is a Private company.

  • What is AGADA Biosciences’s current revenue?

    The current revenue for AGADA Biosciences is 000000.

  • How much funding has AGADA Biosciences raised over time?

    AGADA Biosciences has raised $23.4K.

  • Who are AGADA Biosciences’s investors?

    Invest Nova Scotia, Duchenne UK, Life Sciences Nova Scotia, and Global Business Accelerator have invested in AGADA Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »